MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze HTGC →
    • FindStock Picks / Stock Screener
    • Value · HTGCIntrinsic Value Calculator
    • Invest · HTGCInvestment Case
    • Hold · HTGC5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
HTGC stock logo

HTGC

Hercules Capital, Inc.

$16.83
0.42
 (2.53%)
Exchange:  NYSE
Market Cap:  3.189B
Shares Outstanding:  180.773M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Financial ServicesView sector performance
Industry:  Asset ManagementView industry performance
   
CEO:  Scott Bluestein
Full Time Employees:  100
Address: 
1 North B Street
San Mateo
CA
94401
US
Website:  https://www.htgc.com
Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels, and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, drug platform, development, and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. Within sustainable and renewables, it invests in Vehicle Technology, Energy Generation and Storage, Ag Technology, Advanced Materials, and Industry 4.0. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest, particularly in the areas of software, biotech, and information services. The firm prefers to invest between $5 million and $500 million in equity per transactions. It invests in debt between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in San Mateo, California with additional offices in North America and Europe.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
HTHTGC logoHTGCHercules Capital, Inc.3.2B8.68.89.0%
FSFSK logoFSKFS KKR Capital Corp.3.2B—7.10.0%
AAAAMI logoAAMIAcadian Asset Management3.2B26.016.017.6%
HCHCXY logoHCXYHercules Capital Inc3.2B8.612.59.0%
ABAB logoABAllianceBernstein Holding L.P.3.2B10.410.30.0%
GBGBDC logoGBDCGolub Capital BDC, Inc.3.4B23.19.64.8%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/05 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue494,115430,896547,096
Gross Profit426,495353,745477,253
EBITDA337,674263,432365,433
Operating Income337,484262,966365,160
Net Income337,484262,966339,737

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets3,416,9263,831,5914,584,026
Total Liabilities1,614,2201,842,0102,367,973
Total Stockholders Equity1,802,7061,989,5812,216,053
Total Debt1,560,0641,787,14916,267
Cash and Cash Equivalents98,899113,12456,874

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow68,278-118,088-425,801
Capital Expenditure-88700
Free Cash Flow67,391-118,088-425,801
Net Income337,48431,486-137,340
Net Change in Cash90,137408-56,967

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)650,923.952Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)739,582.419Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)680,653.600Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)466,466.513Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)513,314.983Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)504,700.348Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)368,154.991Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)405,165.282Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)398,359.720Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)31,389.052Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)35,664.367Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)32,822.684Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)1.990Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)2.080Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)1.890Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)5Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)6Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
462.105M  ?P/S
 (TTM)
: 
5.73
?Net Income
 (TTM)
: 
260.135M  ?P/E
 (TTM)
: 
8.6
?Enterprise Value
 (TTM)
: 
5.661B  ?EV/FCF
 (TTM)
: 
-36.76
?Dividend Yield
 (TTM)
: 
11.75%  ?Payout Ratio
 (TTM)
: 
94.96%
?ROE
 (TTM)
: 
15.8%  ?ROIC
 (TTM)
: 
9.01%
?Net Debt
 (TTM)
: 
1.671B  ?Debt/Equity
 (TTM)
: 
1.1
?P/B
 (TTM)
: 
1.33  ?Current Ratio
 (TTM)
: 
1.41

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
8.76Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates HTGC intrinsic value between $2.18 – $4.80 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate HTGC Intrinsic Value

Common questions about HTGC valuation

Is Hercules Capital, Inc. (HTGC) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Hercules Capital, Inc. (HTGC) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is HTGC a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether HTGC trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is HTGC’s P/E ratio?

You can see HTGC’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for HTGC?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is HTGC a good long-term investment?

Whether HTGC fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Hercules Capital, Inc.

  • Hercules Capital, Inc. intrinsic value calculatorEstimate what the business is worth
  • Hercules Capital, Inc. 5-year outlookWhat has to go right, and what could go wrong
HTGC

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

2.53
MarketSnap

Trading Metrics:

Open: 16.57   Previous Close: 16.41
Day Low: 16.57   Day High: 16.88
Year Low: 13.7   Year High: 19.13
Price Avg 50: 16.98   Price Avg 200: 16.13
Volume: 958675   Average Volume: 1.398M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Hercules Capital: Upgrading To A Buy As Rate Hikes Now Cover Refinancing
01-11-2026 22:16
Hercules Capital: Upgrading To A Buy As Rate Hikes Now Cover Refinancing
Hercules Capital Q3 Earnings Call Highlights
30-10-2026 17:15
Hercules Capital Q3 Earnings Call Highlights
Hercules Capital, Inc. (HTGC) Q3 2026 Earnings Call Transcript
29-10-2026 21:09
Hercules Capital, Inc. (HTGC) Q3 2026 Earnings Call Transcript
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Third Quarter 2026
27-10-2026 06:00
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Third Quarter 2026
Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.
16-10-2026 06:00
Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.
Hercules Capital (HTGC) Exceeds Market Returns: Some Facts to Consider
15-10-2026 19:15
Hercules Capital (HTGC) Exceeds Market Returns: Some Facts to Consider

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze HTGC →
    • FindStock Picks / Stock Screener
    • Value · HTGCIntrinsic Value Calculator
    • Invest · HTGCInvestment Case
    • Hold · HTGC5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read